Back to TUDOR INVESTMENT CORP ET AL TUDOR INVESTMENT CORP ET AL

RYTMRYTM

Showing 6 of 19 quarters

Position history for TUDOR INVESTMENT CORP ET ALTUDOR INVESTMENT CORP ET AL's holdings in RHYTHM PHARMACEUTICALS INC

Yes. Tudor Investment holds 13,886 shares of RYTM (Rhythm Pharmaceuticals), worth $1.5M, as of its Q2 2026 13F filing. It reduced the position by 5,760 shares (-29.3%) from Q1 2026. Tudor Investment has held RYTM since Q1 2026, across 2 quarterly 13F filings.

Current Value

$1.5M

Current Shares

13,886

Total Value Change

+$688,348

Total Shares Change

-1,359

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
13,886
-29.3%
$1.5M0.0%$111.03
0
2026-Q1
New
19,646
—
$1.7M0.0%$86.97
36
2025-Q3
Exited
0
-100.0%
$00.0%$100.99
0
2025-Q2
Decreased
4,272
-85.5%
$269,9480.0%$63.19
0
2025-Q1
Increased
29,513
+93.6%
$1.6M0.0%$52.97
41
2024-Q4
New
15,245
—
$853,4150.0%$55.98
34

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used